Skip to content
Screener

GE HealthCare Technologies GEHC EPS (Diluted)

EPS (Diluted) at other companies

OSI Systems, Inc. logo
OSI Systems, Inc.OSIS
$3.27+7.9%
iRadimed logo
iRadimedIRMD
$0.45+21.6%
HTF
Heartflow, Inc.HTFL
-$0.18+87.7%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$1.11-0.9%
Butterfly Network logo
Butterfly NetworkBFLY
-$0.05+16.7%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
-$0.75-78.6%

Other financials

Income statement

See full
Revenue$5.3B+5.8%
Gross profit$2.2B+9.8%
Operating income$739.0M+13.0%
Net income$561.0M+15.4%

Balance sheet

See full
Total debt$10.5B-1.6%
Total equity$11.0B+13.0%
Total assets$37.2B+4.9%

Cash flow

See full
Operating cash flow$168.0M+78.7%
CapEx$100.0M+16.3%
Free cash flow$68.0M+750%

Valuation

See full
Market cap$33.11B-2.3%
P/E16.7×+1.6×
P/S1.6×-0.1×

Profitability

See full
Gross margin39.5%-2.0pp
Operating margin12.9%-1.0pp
Net margin9.3%-1.9pp
FCF margin7.4%-0.4pp

Returns & leverage

See full
Return on equity19.2%-6.4pp
Debt / equity1×-0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: GE HealthCare Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:27 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001932393-26-000046
(In millions, except per share amounts)For the three months ended June 30 / 2026For the three months ended June 30 / 2025For the six months ended June 30 / 2026For the six months ended June 30 / 2025
Net (income) loss attributable to noncontrolling interests(13)(14)(35)(39)
Net income attributable to GE HealthCare$561$486$950$1,049
Earnings per share attributable to GE HealthCare:
Basic$1.24$1.06$2.09$2.30
Diluted1.241.062.082.29
Weighted-average number of shares outstanding:
Basic453457454457
Diluted454458456459

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is GE HealthCare Technologies's EPS (diluted)?
GE HealthCare Technologies (GEHC) reported EPS (diluted) of $1.24 in Q2 2026.
How has GE HealthCare Technologies's EPS (diluted) changed year-over-year?
GE HealthCare Technologies's EPS (diluted) increased by 17.0% year-over-year, from $1.06 to $1.24.
What is the long-term trend for GE HealthCare Technologies's EPS (diluted)?
Over 4 years (2021 to 2025), GE HealthCare Technologies's EPS (diluted) has grown at a -2.0% compound annual growth rate (CAGR), from $4.95 to $4.56.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about GE HealthCare Technologies's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude